Novo Nordisk Says Next-Gen Obesity Drug Reduces Food Noise, Drives Weight Loss

기사 요약

Novo Nordisk presents data showing CagriSema reduces cravings and weight, while real-world patients switching to oral semaglutide also lost weight.